Texas lawmakers are set to study cannabis and psychedelics more closely as they prepare for the state’s next legislative session. Under new directives from Lt. Gov. Dan Patrick and House Speaker Dustin Burrows, key committees will examine how these substances impact public health, safety, and regulation.
In the Senate, officials have been asked to focus on THC products, including potential links to mental health issues, healthcare costs, and criminal justice impacts. The move follows a failed attempt to ban hemp-derived THC products after Gov. Greg Abbott vetoed the proposal, favoring regulation over prohibition.
On the House side, lawmakers will monitor the rollout of a state-supported psychedelic research initiative, particularly studies involving ibogaine as a potential treatment for opioid addiction and other conditions.
Together, the efforts reflect a cautious but evolving approach in Texas—scrutinizing THC while exploring the medical potential of psychedelics. The findings are expected to help shape future policy decisions in one of the country’s more restrictive cannabis states.
Dabbin-Dad Newsroom
